preliminary findings also indicate that itraconazole may hold promise for the prophylaxis of opportunistic fungal infections in patients at risk , for example women with chronic recurrent vaginal candidiasis , immunodeficient patients with chronic mucocutaneous candidiasis , aids patients and patients receiving immunosuppressant drugs .
C0064113
itraconazole
C0006845
chronic mucocutaneous candidiasis